Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-Bromoveratraldehyde is an organic compound characterized by its white to light yellow crystalline or powdery appearance. It is a derivative of veratraldehyde, featuring a bromine atom at the 6th position, which imparts unique chemical properties to the molecule.

5392-10-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 5392-10-9 Structure
  • Basic information

    1. Product Name: 6-Bromoveratraldehyde
    2. Synonyms: 6-BROMOVERATRALDEHYDE;AKOS B005109;TIMTEC-BB SBB003186;6-BROMOVEZATALDEHYDE;2-BROMO-4,5-DIMETHOXYBENZALDEHYDE / 6-BROMOVERATRALDEHYDE;6-BROMOVERATRALDEHYDE 98%;2-BROMO-4,5-DIMETHOXYBENZALEHYDE;4,5-Dimethoxy-2-bromobenzaldehyde
    3. CAS NO:5392-10-9
    4. Molecular Formula: C9H9BrO3
    5. Molecular Weight: 245.07
    6. EINECS: 226-390-4
    7. Product Categories: Aromatic Aldehydes & Derivatives (substituted);Benzaldehyde;Aldehydes;C9;Carbonyl Compounds
    8. Mol File: 5392-10-9.mol
  • Chemical Properties

    1. Melting Point: 150-151 °C(lit.)
    2. Boiling Point: 316.1 °C at 760 mmHg
    3. Flash Point: 145 °C
    4. Appearance: white to light yellow crystals or powder
    5. Density: 1.5955 (rough estimate)
    6. Vapor Pressure: 0.000418mmHg at 25°C
    7. Refractive Index: 1.4730 (estimate)
    8. Storage Temp.: Room temperature.
    9. Solubility: N/A
    10. Water Solubility: Insoluble in water.
    11. Sensitive: Air Sensitive
    12. BRN: 2052355
    13. CAS DataBase Reference: 6-Bromoveratraldehyde(CAS DataBase Reference)
    14. NIST Chemistry Reference: 6-Bromoveratraldehyde(5392-10-9)
    15. EPA Substance Registry System: 6-Bromoveratraldehyde(5392-10-9)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: N/A
    3. Safety Statements: 24/25
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 5392-10-9(Hazardous Substances Data)

5392-10-9 Usage

Uses

Used in Pharmaceutical Industry:
6-Bromoveratraldehyde is used as an intermediate in the synthesis of various pharmaceutical compounds, specifically benzylchromenylamines. These compounds have potential applications in the development of new drugs due to their diverse chemical structures and biological activities.
Used in Chemical Synthesis:
In the field of organic chemistry, 6-Bromoveratraldehyde serves as a valuable building block for the creation of more complex molecules. Its bromine atom can be involved in various chemical reactions, such as substitution, addition, and elimination, making it a versatile starting material for the synthesis of a wide range of organic compounds.
Used in Research and Development:
6-Bromoveratraldehyde is also utilized in research and development settings, where it can be employed to study the effects of structural modifications on the properties and reactivity of organic molecules. This knowledge can be applied to the design and synthesis of new compounds with specific applications in various industries, such as pharmaceuticals, materials science, and agrochemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 5392-10-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,9 and 2 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 5392-10:
(6*5)+(5*3)+(4*9)+(3*2)+(2*1)+(1*0)=89
89 % 10 = 9
So 5392-10-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H9BrO3/c1-12-8-3-6(5-11)7(10)4-9(8)13-2/h3-5H,1-2H3

5392-10-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A13591)  6-Bromoveratraldehyde, 97%   

  • 5392-10-9

  • 5g

  • 470.0CNY

  • Detail
  • Alfa Aesar

  • (A13591)  6-Bromoveratraldehyde, 97%   

  • 5392-10-9

  • 25g

  • 1809.0CNY

  • Detail
  • Alfa Aesar

  • (A13591)  6-Bromoveratraldehyde, 97%   

  • 5392-10-9

  • 100g

  • 5459.0CNY

  • Detail

5392-10-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-Bromoveratraldehyde

1.2 Other means of identification

Product number -
Other names 2-bromo-4,5-dimethoxybenzaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5392-10-9 SDS

5392-10-9Relevant articles and documents

Copolymerization of an indazole ligand into the self-polymerization of dopamine for enhanced binding with metal ions

Fan, Ka Wai,Roberts, Justine J.,Martens, Penny J.,Stenzel, Martina H.,Granville, Anthony M.

, p. 7457 - 7465 (2015)

5,6-Dihydroxy-1H-indazole (DHI) is able to self-polymerize through the same mussel-inspired chemistry responsible for generating poly(dopamine) (PDA), demonstrating the potential to expand this class of catecholamine-exclusive chemistry onto heterocyclic catechol derivatives for the preparation of functional materials. Although DHI exhibits slower polymerization kinetics compared to dopamine, the two chemical species are compatibly polymerizable under the same reaction conditions and allow the preparation of copolymer coatings in different molar ratios. Of these copolymers, the 1:3-copolymer (DHI-to-dopamine ratio) has demonstrated adequate structural stability as a polymer coating. While PDA performs as an intact framework, the incorporated DHI enhances the colloidal stability and provides additional coordinating functionality through the pyrazole moieties. The 1:3-copolymer was fabricated into polymer capsules which exhibit negligible cytotoxicity towards murine dermal fibroblasts (L929) and enhanced binding behaviour towards copper(ii). This represents a new channel for fabricating cargo carriers for biomedical applications that involve the use of transition metal-based species.

Diphyllin and application thereof in preparation of medicine for preventing or treating diabetes mellitus

-

Paragraph 0029-0031, (2020/06/05)

The invention belongs to the technical field of medicine, and particularly relates to diphyllin represented by a formula I and an application of the diphyllin in preparation of medicine for preventingor treating diabetes mellitus, and experiments prove that the compound can improve insulin sensitivity of mice and reduce blood sugar. The compound is expected to be developed into a medicine for preventing or treating diabetes.

Diphyllin Improves High-Fat Diet-Induced Obesity in Mice Through Brown and Beige Adipocytes

Duan, Ya-Nan,Ge, Xiang,Jiang, Hao-Wen,Zhang, Hong-Jie,Zhao, Yu,Li, Jin-Long,Zhang, Wei,Li, Jing-Ya

, (2020/12/28)

Brown adipose tissue (BAT) and beige adipose tissue dissipate metabolic energy and mediate nonshivering thermogenesis, thereby boosting energy expenditure. Increasing the browning of BAT and beige adipose tissue is expected to be a promising strategy for combatting obesity. Through phenotype screening of C3H10-T1/2 mesenchymal stem cells, diphyllin was identified as a promising molecule in promoting brown adipocyte differentiation. In vitro studies revealed that diphyllin promoted C3H10-T1/2 cell and primary brown/beige preadipocyte differentiation and thermogenesis, which resulted increased energy consumption. We synthesized the compound and evaluated its effect on metabolism in vivo. Chronic experiments revealed that mice fed a high-fat diet (HFD) with 100 mg/kg diphyllin had ameliorated oral glucose tolerance and insulin sensitivity and decreased body weight and fat content ratio. Adaptive thermogenesis in HFD-fed mice under cold stimulation and whole-body energy expenditure were augmented after chronic diphyllin treatment. Diphyllin may be involved in regulating the development of brown and beige adipocytes by inhibiting V-ATPase and reducing intracellular autophagy. This study provides new clues for the discovery of anti-obesity molecules from natural products.

COMPOUNDS FOR THE INHIBITION OF UNREGULATED CELL GROWTH

-

Page/Page column 34, (2020/07/14)

The present invention discloses compounds for inhibition of uncontrolled cell proliferation particularly cancer stem cells. Particularly, the invention relates to compounds of Formula I to XXII for the treatment of cancer.

Solvent-free oxidation of benzyl alcohols catalysed by a tetrazole-saccharinate Zn(II) complex under microwave radiation: The role of the ligand and the reaction mechanism

Cristiano, M. Lurdes S.,Fernandes, André L.,Frija, Luís M. T.,Pombeiro, Armando J. L.

, (2020/07/27)

Herein we present an efficient methodology for the microwave-assisted peroxidative oxidation of benzyl alcohols to the corresponding aldehydes by using a novel and stable tetrazole-saccharinate zinc(II) catalyst, along with some insights into the reaction mechanism. This methodology is distinguished by the use of easily available and cheap reagents on the genesis of the zinc catalyst, mild reaction conditions, very short reaction periods (5–20 min) and no need to add an organic solvent. Furthermore, the use of TBHP (70percent. aq.) as oxidizing agent turn this protocol a convenient one for benzyl alcohol oxidation in yields up to 98percent.

Convergent First Total Synthesis of Melovinone: A Densely Substituted 3-Methoxy-4-quinolone Isolated from Melochia tomentosa L

Aguilar, Abel A. Arroyo,Kaufman, Teodoro S.,Larghi, Enrique L.,Ledesma, Gabriela N.,Tirloni, Bárbara

, p. 4253 - 4262 (2019/11/14)

The first total synthesis of melovinone, a nonrutaceous 3-methoxy-4-quinolone alkaloid isolated from Melochia tomentosa L., is reported. The target was acquired in a convergent fashion through the Suzuki-Miyaura cross-coupling reaction between an ortho-nitrobenzoic acid acetonyl ester derivative prepared from vanillin and potassium 5-phenyl-1-pentyltrifluoroborate, obtained from β-phenethyl bromide. The coupling was followed by a chemoselective reduction of the nitro group and a microwave-Assisted and AcOH-promoted cyclization with rearrangement of the resulting acetonyl anthranilate. This afforded a pseudane intermediate, which was selectively methylated on the 3-OH. The synthetic pathway enabled to reach the objective in 11 steps and 18% overall yield. The 1 H NMR spectra of the synthetic and natural product were in full agreement.

Biomimetic Organocatalytic Approach to 4-Arylquinolizidine Alkaloids and Application in the Synthesis of (-)-Lasubine II and (+)-Subcosine II

Virk, Seerat,Pansare, Sunil V.

supporting information, p. 5524 - 5528 (2019/07/08)

An enantioselective, biomimetic organocatalytic synthesis of 4-arylquinolizidin-2-ones, key intermediates in the synthesis of several Lythraceae alkaloids, was developed. The methodology features S-proline-mediated Mannich/aza-Michael reactions of readily available arylideneacetones and Δ1-piperideine. The total syntheses of (-)-lasubine II and (+)-subcosine II as well as the formal syntheses of structurally related Lythraceae alkaloids were achieved. The use of Δ1-pyrroline in the Mannich/aza-Michael reaction provides enantiomerically enriched 5-arylindolizidin-7-ones, which are precursors to nonopiate antinociceptive agents.

Synthesis of substituted biphenyl methylene indolinones as apoptosis inducers and tubulin polymerization inhibitors

Donthiboina, Kavitha,Anchi, Pratibha,Sri Ramya,Karri, Shailaja,Srinivasulu, Gannoju,Godugu, Chandraiah,Shankaraiah, Nagula,Kamal, Ahmed

, p. 210 - 223 (2019/02/06)

A new series of biphenyl methylene indolinones has been designed, synthesized and evaluated for their in vitro antiproliferative activity against various cancer cell lines like DU-145 (prostate cancer cell line), 4T1 (mouse breast cancer cell line), MDA-MB-231 (human breast cancer cell line), BT-549 (human breast cancer cell line), T24 (human urinary bladder carcinoma cell line), and HeLa (cervical cancer cell line). Among the series, compound 10e showed potent in vitro cytotoxic activity against HeLa and DU-145 cancer cell lines with IC50 value of 1.74 ± 0.69 μM and 1.68 ± 1.06 μM respectively. To understand the underlying mechanism of most potent cytotoxic compound 10e, various mechanistic studies were carried out on DU-145 cell lines. Cell cycle analysis results revealed that these conjugates affect both G0/G1 and G2/M phase of the cycle, tubulin binding assay resulted that compound 10e interrupting microtubule network formation by inhibiting tubulin polymerization with IC50 value of 4.96 ± 0.05 μM. Moreover, molecular docking of 10e on colchicine binding site of the tubulin explains the interaction of 10e with tubulin. Clonogenic assay indicated inhibition of colony formation by compound 10e in a dose dependent manner. In addition, morphological changes were clearly observed by AO/EB and DAPI staining studies. Moreover, ROS detection using DCFDA, JC-1, and annexin V-FITC assays demonstrated the significant apoptosis induction by 10e.

Discovery of Novel Bromophenol-Thiosemicarbazone Hybrids as Potent Selective Inhibitors of Poly(ADP-ribose) Polymerase-1 (PARP-1) for Use in Cancer

Guo, Chuanlong,Wang, Lijun,Li, Xiuxue,Wang, Shuaiyu,Yu, Xuemin,Xu, Kuo,Zhao, Yue,Luo, Jiao,Li, Xiangqian,Jiang, Bo,Shi, Dayong

, p. 3051 - 3067 (2019/03/29)

Poly(ADP-ribose) polymerase-1 (PARP-1) is a new potential target for anticancer drug discovery. A series of bromophenol-thiosemicarbazone hybrids as PARP-1 inhibitors were designed, synthesized, and evaluated for their antitumor activities. Among them, the most promising compound, 11, showed excellent selective PARP-1 inhibitory activity (IC50 = 29.5 nM) over PARP-2 (IC50 > 1000 nM) and potent anticancer activities toward the SK-OV-3, Bel-7402 and HepG2 cancer cell lines (IC50 = 2.39, 5.45, and 4.60 μM), along with inhibition of tumor growth in an in vivo SK-OV-3 cell xenograft model. Further study demonstrated that compound 11 played an antitumor role through multiple anticancer mechanisms, including the induction of apoptosis and cell cycle arrest, cellular accumulation of DNA double-strand breaks, DNA repair alterations, inhibition of H2O2-triggered PARylation, antiproliferative effects via the production of cytotoxic reactive oxygen species, and autophagy. In addition, compound 11 displayed good pharmacokinetic characteristics and favorable safety. These observations demonstrate that compound 11 may serve as a lead compound for the discovery of new anticancer drugs.

Palladium-catalyzed ortho-C(sp2)[sbnd]H bromination of benzaldehydes via a monodentate transient directing group strategy

Yong, Qiyun,Sun, Bing,Zhang, Fang-Lin

supporting information, (2019/11/03)

A facile and efficient monodentate transient directing group strategy was developed to enable the palladium-catalyzed ortho-C(sp2)[sbnd]H bromination of benzaldehydes. A broad scope of benzaldehydes were transformed into the desired products by employing 2-amino-5-chlorobenzotrifluoride as a monodentate transient directing group, demonstrating good functional group tolerance. Mild reaction conditions and no requirement for a silver salt are also features of this strategy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5392-10-9